An iridium( iii )-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
This is the first report of a metal complex that targets the BRD4-acylated histone protein-protein interaction (PPI).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent improvements in structural biology and chemical reactivity have enabled the design and development of potent and selective covalent PPI inhibitors.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“Aided by recent advancements in structural biology and chemistry, covalent inhibitors have emerged as a potentially effective approach towards PPI inhibition [37, 38].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Research works printed but not linked: 3
- Florence, 2001, Front. Biosci., 6, d1008
- Chung, 2012, Drug Discovery Today: Ther. Strategies, 9, e111
- Chen, 2014, BioMed Res. Int., 2014, 232870
Cited by
Alessio, E. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201600986 · Cited by 388
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
Zamora, A., Vigueras, G., Rodríguez, V., Santana, M. D., & Ruiz, J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.01.010 · Cited by 345
Ran, X., & Gestwicki, J. E. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.004 · Cited by 263
Potential biomedical applications of marine algae
Wang, H.-M. D., Li, X.-C., Lee, D.-J., & Chang, J.-S. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2017.05.198 · Cited by 217
Sohrabi, M., Saeedi, M., Larijani, B., & Mahdavi, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113308 · Cited by 206
Targeting Brd4 for cancer therapy: inhibitors and degraders
Duan, Y., Guan, Y., Qin, W., Zhai, X., Yu, B., & Liu, H. (2018) · MedChemComm · doi:10.1039/c8md00198g · Cited by 161
Wang, W., Vellaisamy, K., Li, G., Wu, C., Ko, C.-N., Leung, C., & Ma, D. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03114 · Cited by 162
Self-citationTang, P., Zhang, J., Liu, J., Chiang, C.-M., & Ouyang, L. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01487 · Cited by 135
Recent advances of iridium(III) metallophosphors for health-related applications
Ho, P., Ho, C., & Wong, W. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213267 · Cited by 149
Liu, L., Wang, W., Huang, S., Hong, Y., Li, G., Lin, S., Tian, J., Cai, Z., Wang, H.-M. D., Ma, D., et al. (2017) · Chemical Science · doi:10.1039/c7sc00311k · Cited by 127
Self-citationHe, L., Wang, K., Zheng, Y., Cao, J., Zhang, M., Tan, C., Ji, L., & Mao, Z. (2018) · Dalton Transactions · doi:10.1039/c8dt00783g · Cited by 123
Zeng, L., Chen, Y., Liu, J., Huang, H., Guan, R., Ji, L., & Chao, H. (2016) · Scientific Reports · doi:10.1038/srep19449 · Cited by 116
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Kulikowski, E., Rakai, B. D., & Wong, N. C. W. (2021) · Medicinal Research Reviews · doi:10.1002/med.21730 · Cited by 102
“There is now a considerable amount of data, generated by various groups, demonstrating differential outcomes of pan‐ versus selective BD inhibition.16,38,45,157,210 In one investigational study, gene expression in hepatocellular carcinoma cell line (HepG2 cells) following treatment with the pan‐BETi JQ1 was contrasted…”
BackgroundInfluentialHalf-sandwich iridium N-heterocyclic carbene anticancer complexes
Wang, C., Liu, J., Tian, Z., Tian, M., Tian, L., Zhao, W., & Liu, Z. (2017) · Dalton Transactions · doi:10.1039/c7dt00575j · Cited by 102
Recent development of transition metal complexes with in vivo antitumor activity
Liang, J., Zhong, H., Yang, G., Vellaisamy, K., Ma, D., & Leung, C. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.002 · Cited by 101
Self-citationThe design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Aided by recent advancements in structural biology and chemistry, covalent inhibitors have emerged as a potentially effective approach towards PPI inhibition [37, 38].”
BackgroundSelf-citationLiu, C., Chen, Z., Wang, Z., Li, W., Ju, E., Yan, Z., Liu, Z., Ren, J., & Qu, X. (2015) · Nanoscale · doi:10.1039/c5nr07719b · Cited by 84
Computational Prediction of RNA-Binding Proteins and Binding Sites
Si, J.-N., Cui, J. H., Cheng, J. Q., & Wu, R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125952 · Cited by 90
Yang, C., Wang, W., Liang, J., Li, G., Vellaisamy, K., Wong, C., Ma, D., & Leung, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00133 · Cited by 83
Self-citationLiu, J., Jin, C., Yuan, B., Chen, Y., Liu, X., Ji, L., & Chao, H. (2017) · Chemical Communications · doi:10.1039/c7cc05518h · Cited by 80
Activity Enhancement of G‐Quadruplex/Hemin DNAzyme by Flanking d(CCC)
Chang, T., Gong, H., Ding, P., Liu, X., Li, W., Bing, T., Cao, Z. C., & Shangguan, D. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201504797 · Cited by 80
Bertrand, B., Fernández‐Cestau, J., Angulo, J., Cominetti, M. M. D., Waller, Z. A. E., Searcey, M., O'Connell, M. A., & Bochmann, M. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b00339 · Cited by 77
Chen, Y.-T., Kao, C.-J., Huang, H., Huang, S., Chen, C., Lin, Y., Wen, Z., & Wang, H. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.005 · Cited by 76
Yang, G., Ko, C.-N., Zhong, H., Leung, C., & Ma, D. (2019) · Cancers · doi:10.3390/cancers11010092 · Cited by 77
“The cell cytotoxicity and proliferation assay were detected by MTT assay and colony formation assay [57].”
MethodSelf-citationPrachařová, J., Vigueras, G., Novohradský, V., Cutillas, N., Janiak, C., Kostrhunová, H., Kašpárková, J., Ruiz, J., & Brabec, V. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201705362 · Cited by 76
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
Wang, F., Chen, M., Hu, X.-Y., Ye, R., Tan, C., Ji, L., & Mao, Z. (2016) · Scientific Reports · doi:10.1038/srep38954 · Cited by 72
Zhang, P., Wang, Y., Qiu, K., Zhao, Z., Hu, R., He, C., Zhang, Q., & Chao, H. (2017) · Chemical Communications · doi:10.1039/c7cc07776a · Cited by 67
Yellol, J., Pérez, S. A., Yellol, G. S., Zajac, J., Donaire, A., Vigueras, G., Novohradský, V., Janiak, C., Brabec, V., & Ruiz, J. (2016) · Chemical Communications · doi:10.1039/c6cc07909a · Cited by 69
Li, J., Tian, Z., Xu, Z., Zhang, S., Feng, Y., Zhang, L., & Liu, Z. (2018) · Dalton Transactions · doi:10.1039/c8dt02963f · Cited by 69
An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator
Liu, L., Lu, L., Zhong, H., He, B., Kwong, D. W. J., Ma, D., & Leung, C. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00375 · Cited by 66
Self-citationCheng, S., Qu, Y. Q., Wu, J., Yang, G., Liu, H., Wang, W., Huang, Q., Chen, F., Li, G., Wong, C., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.024 · Cited by 66
Self-citationDeveloping an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin
Zhang, Z., Zhang, J., Yang, T., Li, S., Xu, G., Liang, H., & Yang, F. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00001 · Cited by 69
Yang, G., Zhong, H., Ko, C.-N., Wong, S.-Y., Vellaisamy, K., Ye, M., Ma, D., & Leung, C. (2018) · Chemical Communications · doi:10.1039/c7cc09384e · Cited by 67
Self-citationMa, W., Guo, L., Tian, Z., Zhang, S., He, X., Li, J., Yang, Y., & Liu, Z. (2019) · Dalton Transactions · doi:10.1039/c9dt00999j · Cited by 64
Hydrogel-based artificial enzyme for combating bacteria and accelerating wound healing
Qiu, H., Pu, F., Liu, Z., Liu, X., Dong, K., Liu, C., Ren, J., & Qu, X. (2020) · Nano Research · doi:10.1007/s12274-020-2636-9 · Cited by 64
Mari, C., Huang, H., Rubbiani, R., Schulze, M., Würthner, F., Chao, H., & Gasser, G. (2016) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201600516 · Cited by 63
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development
Chen, J., Tang, P., Wang, Y., Wang, J., Yang, C., Li, Y., Yang, G., Wu, F., Zhang, J., & Ouyang, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01835 · Cited by 62
Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes
Stringer, T., Seldon, R., Liu, N., Warner, D. F., Tam, C. C., Cheng, L. W., Land, K. M., Smith, P. J., Chibale, K., & Smith, G. S. (2017) · Dalton Transactions · doi:10.1039/c7dt01952a · Cited by 60
Kharenko, O. A., Patel, R. G., Brown, S. D., Calosing, C., White, A., Lakshminarasimhan, D., Suto, R. K., Duffy, B. C., Kitchen, D. B., McLure, K. G., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00666 · Cited by 52
Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-α
Kang, T., Mao, Z., Ng, C. E., Wang, M., Wang, W., Wang, C., Lee, S. M., Wang, Y., Leung, C., & Ma, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00112 · Cited by 56
Self-citationSzymaszek, P., Tyszka‐Czochara, M., & Ortyl, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116648 · Cited by 57
“Half-sandwich” Schiff-base Ir(III) complexes as anticancer agents
Mou, Z., Deng, N., Zhang, F., Zhang, J., Cen, J., & Zhang, X. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.027 · Cited by 55
Ma, W., Zhang, S., Tian, Z., Xu, Z., Zhang, Y., Xia, X., Chen, X., & Liu, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111599 · Cited by 55
Bai, L., Fei, W., Gu, Y., He, M., Du, F., Zhang, W.-Y., Yang, L.-L., & Liu, Y. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111014 · Cited by 55
Luminescent iridium( iii ) complexes as COX-2-specific imaging agents in cancer cells
Liu, C., Yang, C., Lu, L., Wang, W., Tan, W., Leung, C., & Ma, D.-L. (2017) · Chemical Communications · doi:10.1039/c6cc08109f · Cited by 54
Self-citationLuminescent Iridium(III) Complex Labeled DNA for Graphene Oxide-Based Biosensors
Zhao, Q., Zhou, Y., Li, Y., Gu, W., Zhang, Q., & Liu, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04324 · Cited by 52
Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies
Ma, D., Wu, C., Cheng, S., Lee, F., Han, Q., & Leung, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020341 · Cited by 56
Self-citationAn optimized BRD4 inhibitor effectively eliminates NF-κB-driven triple-negative breast cancer cells
Yang, G., Song, Y., Wang, W., Han, Q., Ma, D., & Leung, C. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105158 · Cited by 52
Self-citationThe Bond Order of C2 from a Strictly N‐Representable Natural Orbital Energy Functional Perspective
Piris, M., López, X., & Ugalde, J. M. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201504491 · Cited by 50
Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent
Lü, X., Liu, Y., Orvig, C., Liang, H., & Chen, Z. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02047 · Cited by 52
Huang, H., Zhang, P., Chen, Y., Qiu, K., Jin, C., Ji, L., & Chao, H. (2016) · Dalton Transactions · doi:10.1039/c6dt01270a · Cited by 50
Yu, W., Li, C., Zhang, W., Xia, Y., Li, S., Lin, J., Yu, K., Liu, M., Yang, L. F., Luo, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01489 · Cited by 48
Approaches towards understanding the mechanism-of-action of metallodrugs
Xiong, X., Liu, L., Mao, Z., & Zou, T. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214311 · Cited by 49
Kang, J., Lee, S. J. C., Nam, J. S., Lee, H. J., Kang, M., Korshavn, K. J., Kim, H., Cho, J., Ramamoorthy, A., Rhee, H., et al. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604751 · Cited by 45
Mukhopadhyay, S., Singh, R. S., Paitandi, R. P., Sharma, G., Koch, B., & Pandey, D. S. (2017) · Dalton Transactions · doi:10.1039/c7dt01015j · Cited by 44
Kumar, V., Lakshman, P. K. C., Prasad, T. K., Manjunath, K., Bairy, S. G., Vasu, A. S., Ganavi, B., Jasti, S., & Kamariah, N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23864 · Cited by 51
Yang, C., Wang, W., Chen, L., Liang, J., Lin, S., Lee, M.-Y., Ma, D., & Leung, C. (2016) · Chemical Communications · doi:10.1039/c6cc04938a · Cited by 42
Self-citationLabelling proteins and peptides with phosphorescent d6 transition metal complexes
Connell, T. U., & Donnelly, P. S. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.12.001 · Cited by 42
Tian, X. R., Tang, H. F., Tian, X. L., Hu, J. J., Huang, L. L., & Gustafson, K. R. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0012 · Cited by 44
Cheng, S., Yang, G., Wang, W., Ma, D., & Leung, C. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.06.005 · Cited by 44
Self-citationSun, P., Zhang, Y., Ran, X., Liu, C., Wang, Z., Ren, J., & Qu, X. (2017) · Nano Research · doi:10.1007/s12274-017-1947-y · Cited by 36
Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
Wu, K., Lei, P.-M., Liu, H., Wu, C., Leung, C., & Ma, D. (2019) · Molecules · doi:10.3390/molecules24244428 · Cited by 36
Self-citationLü, X., Liu, Y.-C., Orvig, C., Liang, H., & Chen, Z. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111567 · Cited by 35
Novohradský, V., Yellol, J., Stuchlíková, O., Santana, M. D., Kostrhunová, H., Yellol, G. S., Kašpárková, J., Bautista, D. K. M., Ruiz, J., & Brabec, V. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703581 · Cited by 37
Itoh, Y., Aihara, K., Mellini, P., Tojo, T., Ota, Y., Tsumoto, H., Solomon, V. R., Zhan, P., SUZUKI, M. T., Ogasawara, D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01323 · Cited by 36
Rhun, É. L., von Achenbach, C., Lohmann, B., Silginer, M., Schneider, H., Meetze, K. A., Szabó, E., & Weller, M. (2018) · International Journal of Cancer · doi:10.1002/ijc.32069 · Cited by 33
Ma, W., Ge, X., Xu, Z., Zhang, S., He, X., Li, J., Xia, X., Chen, X., & Liu, Z. (2019) · ACS Omega · doi:10.1021/acsomega.9b01863 · Cited by 33
Chou, H.-Y., Ma, D., Leung, C., Chiu, C., Hour, T., & Wang, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4946902 · Cited by 36
Self-citationAnticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
Yang, C., Wang, W., Li, G., Zhong, H., Dong, Z., Wong, C., Kwong, D. W. J., Ma, D., & Leung, C. (2017) · Scientific Reports · doi:10.1038/srep42860 · Cited by 39
Self-citationRETRACTED: A 7-methoxybicoumarin derivative selectively inhibits BRD4 BD2 for anti-melanoma therapy
Yang, G., Wang, W., Lei, P.-M., Leung, C., & Ma, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.194 · Cited by 32
Self-citationRetractedRevisiting metallodrugs for the treatment of skin cancers
Manzano, C. M., Nakahata, D. H., & de Paiva, R. E. F. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214506 · Cited by 32
Li, G., Li, D., Wu, C., Li, S., Chen, F., Li, P., Ko, C.-N., Wang, W., Lee, S. M., Lin, L., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00804-1 · Cited by 32
Self-citationMeng, T., Qin, Q., Chen, Z., Zou, H., Wang, K., & Liang, F. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112192 · Cited by 31
Selvam, P., De, S., Paira, P., Kumar, S. K. A., Ramasamy, S. K., Moorthy, A., Ghosh, A., Kuo, Y., Banerjee, S., & Kumar, J. S. (2022) · Dalton Transactions · doi:10.1039/d2dt02237k · Cited by 31
Metal complexes as “protein surface mimetics”
Hewitt, S. H., & Wilson, A. J. (2016) · Chemical Communications · doi:10.1039/c6cc03457h · Cited by 31
Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments
Długosz, O., Matyjasik, W., Hodacka, G., Szostak, K., Matysik, J., Krawczyk, P., Piasek, A., Pulit‐Prociak, J., & Banach, M. (2023) · Nanomaterials · doi:10.3390/nano13061130 · Cited by 30
A reaction-based luminescent switch-on sensor for the detection of OH − ions in simulated wastewater
Wu, C., Vellaisamy, K., Yang, G., Dong, Z., Leung, C., Liu, J., & Ma, D.-L. (2017) · Dalton Transactions · doi:10.1039/c7dt00633k · Cited by 28
Self-citationMuddassir, M., Soni, K. V., Sangani, C. B., AlArifi, A. S., Afzal, M. F., Abduh, N. A. Y., Duan, Y., & Bhadja, P. (2020) · RSC Advances · doi:10.1039/d0ra07971e · Cited by 29
Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity
Qin, L.-Q., Liang, C.-J., Zhou, Z., Qin, Q., Wei, Z., Tan, M., & Liang, H. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115948 · Cited by 27
A rhodium(III)-based inhibitor of autotaxin with antiproliferative activity
Kang, T., Wang, W., Zhong, H., Liang, J., Ko, C.-N., Lu, J., Chen, X., Ma, D., & Leung, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.032 · Cited by 28
Self-citationInhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
Liu, L., He, B., Miles, J. A., Wang, W., Mao, Z., Che, W. I., Lu, J., Chen, X., Wilson, A. J., Ma, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7369 · Cited by 26
Self-citationXu, Z., Yang, Y., Jia, X., Guo, L., Ge, X., Zhong, G., Chen, S., & Liu, Z. (2020) · Inorganic Chemistry Frontiers · doi:10.1039/c9qi01492f · Cited by 27
De, S., Kumar, R. S., Gauthaman, A., Kumar, S. K. A., Paira, P., Moorthy, A., & Banerjee, S. (2020) · Inorganica Chimica Acta · doi:10.1016/j.ica.2020.120066 · Cited by 25
Yang, J., Wang, F., Huang, S., Feng, T., Xiong, K., Chen, Y., & Chao, H. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505689 · Cited by 21
Epigenetic modulation by inorganic metal complexes
Leung, C., Liu, L., Leung, K., & Ma, D. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.03.014 · Cited by 24
Self-citationNovel approaches to targeting BRD4
Kharenko, O. A., & Hansen, H. C. (2017) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2017.10.003 · Cited by 22
Mouhsine, H., Guillemain, H., Moreau, G., Fourati, N., Zerrouki, C., Baron, B., Desallais, L., Gizzi, P., Nasr, N. B., Perrier, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03427-z · Cited by 20
Jiang, Y., Zhou, L. Y., Cui, R., Li, Y., Zhao, X., & Zhang, H. (2016) · Dyes and Pigments · doi:10.1016/j.dyepig.2016.01.011 · Cited by 19
Aradhyula, B. P. R., Kalidasan, M., Gangele, K., Deb, D. K., Shepherd, S. L., Phillips, R. M., Poluri, K. M., & Kollipara, M. R. (2017) · ChemistrySelect · doi:10.1002/slct.201601926 · Cited by 19
Ko, C.-N., Wu, C., Li, G., Leung, C., Liu, J., & Ma, D. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.06.042 · Cited by 19
Self-citationManav, N., Janaagal, A., & Gupta, I. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215798 · Cited by 18
Filipović, N. R., Bjelogrlić, S., Todorović, T. R., Blagojević, V., Muller, C. D., Marinković, А., Vujčić, M. T., Janović, B. S., Malešević, A., Begović, N., et al. (2016) · RSC Advances · doi:10.1039/c6ra24604d · Cited by 17
Blair, C. M., Walsh, N. M., Littman, B. H., Marcoux, F. W., & Baillie, G. S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5489-4 · Cited by 17
“The concept of developing protein-protein interaction inhibitors to treat melanoma, however, has previously been investigated with small molecule PPI inhibitors of the complex between bromodomain-containing protein 4 (BRD4) and acetylated histone having been developed [34].”
BackgroundAntagonizing STAT5B dimerization with an osmium complex
Liu, L., Wang, W., Kang, T., Liang, J., Liu, C., Kwong, D. W. J., Wong, V. K. W., Ma, D., & Leung, C. (2016) · Scientific Reports · doi:10.1038/srep36044 · Cited by 16
Self-citationBasava Punna Rao, A., Addepally, U., Thulluri, C., Bethu, M. S., Venkateswara Rao, J., Deb, D. K., Sarkar, B., Kaminsky, W., & Kollipara, M. R. (2016) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2016.10.018 · Cited by 16
Anjong, T. F., Kim, G., Jang, H. Y., Yoon, J., & Kim, J. (2016) · New Journal of Chemistry · doi:10.1039/c6nj02890j · Cited by 16
Highly selective Electrochemiluminescent probe to histidine
Zhou, Y., Xie, K. M., Kong, L., Chen, F., & Sun, D. (2017) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2017.05.054 · Cited by 15
Burgoyne, A. R., Kaschula, C. H., Parker, M. I., & Smith, G. S. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700704 · Cited by 15
Wu, K., Chen, Q., Leung, C., Sun, N., Gao, F., & Chen, Z. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103878 · Cited by 14
Self-citationA novel iridium( iii ) complex for sensitive HSA phosphorescence staining in proteome research
Wang, Y., Huang, H., Ge, C., Chen, H., Xu, T., Tang, Q., Zhu, H., Zhang, Q., & Zhang, P. (2018) · Chemical Communications · doi:10.1039/c8cc01597j · Cited by 14
Metadata
- Authors
- Zhong, H.-J., Lu, L., Leung, K.-H., Wong, C. C. L., Peng, C., Yan, S.-C., Ma, D.-L., Cai, Z., David Wang, H.-M., & Leung, C.-H.
- Affiliations
- University of Macau (MO)
- Hong Kong Baptist University (HK)
- Chinese Academy of Sciences (CN)
- Hong Kong Polytechnic University (HK)
- Department of Fragrance and Cosmetic Science
- Corresponding author
- Ma, Dik-Lung
- Cai, Zongwei
- Leung, Chung-Hang
- ORCID
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 6
- Issue
- 10
- Pages
- 5400-5408
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC5510529
- OpenAlex
- W4247705075
- Cited by
- 138
- References
- 59
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 15 · 2019: 11 · 2018: 12 · 2017: 30 · 2016: 27 · 2015: 4
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Chemical Science (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HKBU Institutional Repository (Hong Kong Baptist University) (submittedVersion, other-oa)
- PolyU Institutional Research Archive (Hong Kong Polytechnic University) (submittedVersion)
- Funders
- Hong Kong Baptist University (FRG2/14-15/004)
- Health and Medical Research Fund (HMRF/13121482, HMRF/14130522)
- Science and Technology Development Fund (103/2012/A3, 098/2014/A2)
- Universidade de Macau (MYRG091(Y3-L2)-ICMS12-LCH, MYRG2015-00137-ICMS-QRCM, MRG023/LCH/2013/ICMS)
- The Research Grants Council, University Grants Committee, Hong Kong (HKBU/201811, HKBU/204612, HKBU/201913)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- iridium(III) complexes, BRD4, protein-protein interaction inhibitors, epigenetic inhibitors, anticancer agents, melanoma, metal-based anticancer agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.